Smith+Nephew to acquire Integrity Orthopaedics

Smith+Nephew has agreed to acquire Integrity Orthopaedics in a strategic acquisition within the Medical Technology sector. The transaction, valued at USD 225 million, involves a consideration structure comprising both cash and an earn-out component. This deal was announced and completed on 21 January 2026, marking a swift conclusion to the negotiations between the two parties. The target company operates primarily within the United States, aligning with the buyer's existing portfolio in the region.

The acquisition represents a significant expansion for Smith+Nephew into the orthopaedic space, solidifying its position in the global medical technology market. As a completed transaction, the deal is no longer subject to pending regulatory approvals or closing conditions. The immediate integration of Integrity Orthopaedics into the buyer's operations is now underway, following the finalisation of the purchase agreement. This strategic move underscores the ongoing consolidation trends within the healthcare industry, where established players seek to enhance their product offerings through targeted acquisitions of specialised firms. The transaction stands as a definitive example of cross-border growth strategy in the current economic climate.